Log in

6622 Zhaoke Ophthalmology Ltd. HKEX · China

Zhaoke Ophthalmology (6622) news

Zhaoke Ophthalmology Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 6622, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Zhaoke Ophthalmology news

We have not published a story on Zhaoke Ophthalmology yet. When there is news, it will appear here.

Questions about Zhaoke Ophthalmology

What is the ticker symbol of Zhaoke Ophthalmology?

Zhaoke Ophthalmology Ltd. trades under the ticker 6622 on HKEX.

Where is Zhaoke Ophthalmology listed?

Zhaoke Ophthalmology Ltd. is listed on HKEX.

Which country or territory is Zhaoke Ophthalmology listed under?

Our directory records Zhaoke Ophthalmology Ltd. under China.

What does Zhaoke Ophthalmology do?

Our directory classifies Zhaoke Ophthalmology Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Zhaoke Ophthalmology?

The ISIN recorded for Zhaoke Ophthalmology Ltd. is KYG989M51017.

Does aibio.space cover Zhaoke Ophthalmology?

aibio.space lists Zhaoke Ophthalmology Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Zhaoke Ophthalmology?

Companies in our directory listed in the same country and business area as Zhaoke Ophthalmology: Livzon Pharmaceutical Group, BGM Group, Zhejiang Int'l Group Co., Zhejiang Shapuaisi Pharmaceutical Co., Yifan Pharmaceutical Co., Jiangsu Aidea Pharmaceutical Group Co..

Investor discussion: Zhaoke Ophthalmology

Members talk about Zhaoke Ophthalmology (6622). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Zhaoke Ophthalmology, newest first. Each line links the filing it comes from.

  1. Mergers

    Transaction under the Listing Rules: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024 AND DISCLOSEABLE TRANSACTION IN RELATION TO SUBSCRIPTION OF WEALTH MANAGEMENT PRODUCT. Source

Press releases

Headlines of Zhaoke Ophthalmology's own announcements, newest first. Each opens the full release on the newswire that carried it.

  1. HKEXnews

    VOLUNTARY ANNOUNCEMENT - ZHAOKE OPHTHALMOLOGY'S MANUFACTURING FACILITY OBTAINS GMP CERTIFICATION FROM THE THERAPEUTIC GOODS ADMINISTRATION OF AUSTRALIA ("TGA")

  2. HKEXnews

    NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM

  3. HKEXnews

    NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM

  4. HKEXnews

    VOLUNTARY ANNOUNCEMENT - CARBACHOL AND BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION (YUVEZZI) MET THE PRIMARY ENDPOINT IN THE PHASE II STUDY IN CHINESE PATIENTS WITH PRESBYOPIA

  5. HKEXnews

    INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026

  6. HKEXnews

    VOLUNTARY ANNOUNCEMENT - ENTERING AN EXCLUSIVE DISTRIBUTION AND PROMOTION AGREEMENT WITH PHARMENTUM BIOPHARMA TO COMMERCIALIZE EPINASTINE HYDROCHLORIDE EYE DROPS IN CHINA (EXCLUDING HONG KONG, MACAU AND TAIWAN)

  7. HKEXnews

    VOLUNTARY ANNOUNCEMENT - INNOVATIVE PRESBYOPIA DRUG YUVEZZI APPROVED BY THE PHARMACEUTICAL ADMINISTRATION BUREAU OF THE GOVERNMENT OF THE MACAU SPECIAL ADMINISTRATIVE REGION

  8. HKEXnews

    VOLUNTARY ANNOUNCEMENT - ENTERED INTO A DEFINITIVE AGREEMENT FOR THE ACQUISITION OF THE GLOBAL RIGHTS TO NVK002 (ATROPINE SULFATE EYE DROPS)

  9. HKEXnews

    VOLUNTARY ANNOUNCEMENT - INNOVATIVE PRESBYOPIA DRUG YUVEZZI APPROVED FOR USE AT BOAO SUPER HOSPITAL AS A CLINICALLY URGENT IMPORTED DRUG

  10. HKEXnews

    VOLUNTARY ANNOUNCEMENT - REGISTRATION APPLICATION FOR ATROPINE SULFATE EYE DROPS (0.02 STRENGTH) ACCEPTED FOR EVALUATION BY AUSTRALIAS THERAPEUTIC GOODS ADMINISTRATION

  11. HKEXnews

    VOLUNTARY ANNOUNCEMENT INTENTION TO CONDUCT ON-MARKET SHARE REPURCHASE

  12. HKEXnews

    VOLUNTARY ANNOUNCEMENT - ENTERING INTO DISTRIBUTION AND SUPPLY AGREEMENT WITH PT. ERELA TO COMMERCIALIZE CsA OPHTHALMIC GEL IN INDONESIA

  13. HKEXnews

    AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION

  14. HKEXnews

    POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON MAY 15, 2026

  15. HKEXnews

    CONTINUING CONNECTED TRANSACTIONS IN RELATION TO RENEWAL OF MASTER CMO SERVICE AGREEMENT

  16. HKEXnews

    NOTICE OF ANNUAL GENERAL MEETING

  17. HKEXnews

    PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION

  18. HKEXnews

    ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025

  19. HKEXnews

    VOLUNTARY ANNOUNCEMENT - ZHAOKE OPHTHALMOLOGY'S PARTNER TENPOINT THERAPEUTICS, LTD. RECEIVES FDA APPROVAL FOR BRIMOCHOL PF IN THE UNITED STATES

  20. HKEXnews

    VOLUNTARY ANNOUNCEMENT - ADVANCING COMMERCIALIZATION OF BRIMOCHOL PF FOR PRESBYOPIA IN SINGAPORE AND VIETNAM THROUGH PARTNERSHIPS WITH AFT AND SENJU

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:6622 on TradingView.

Listing details

Zhaoke Ophthalmology Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 6622, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Zhaoke Ophthalmology Ltd.
Ticker
6622
Listing
HKEX
Country or territory
China
Business scope
Pharmaceuticals: Major
ISIN
KYG989M51017
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.